(Q54561040)

31 May 2018

title

Pharmacodynamics of subcutaneous recombinant human interleukin-10 in healthy volunteers. (English)

1 reference

31 May 2018

1 reference

Huhn RD

1

1 reference

31 May 2018

Radwanski E

2

1 reference

31 May 2018

Gallo J

3

1 reference

31 May 2018

Affrime MB

4

1 reference

31 May 2018

Sabo R

5

1 reference

31 May 2018

Gonyo G

6

1 reference

31 May 2018

Monge A

7

1 reference

31 May 2018

Cutler DL

8

1 reference

31 May 2018

language of work or name

English

0 references

publication date

1 August 1997

1 reference

31 May 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

31 May 2018

volume

62

1 reference

31 May 2018

issue

2

1 reference

31 May 2018

page(s)

171-180

1 reference

31 May 2018

Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990065-5

Detection of tumor necrosis factor soluble receptor p55 in blood samples from healthy and endotoxemic humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990065-5

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990065-5

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990065-5

Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990065-5

Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990065-5

The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990065-5

Interleukin 10 protects mice from lethal endotoxemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990065-5

Interleukin-10 gene knock-out mice: a model of chronic inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990065-5

Inhibition of Thl responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990065-5

The phenomenon of the acute phase response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990065-5

Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990065-5

Cytokine mRNA expression during an in vitro response of human B lymphocytes: kinetics of B cell tumor necrosis factor alpha, interleukin (IL)6, IL-10, and transforming growth factor beta 1 mRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990065-5

Concentrations of immunoreactive human tumor necrosis factor alpha produced by human mononuclear cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990065-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-9236(97)90065-5

1 reference

31 May 2018

1 reference

31 May 2018